视网膜色素变性的发病机制及中医药治疗进展  

Pathogenesis of Retinitis Pigmentosa and Advances in Traditional Chinese Medicine Treatment

作　　者：虞柯慧 郑燕林[2] 

机构地区：[1]成都中医药大学眼科学院,四川 成都 [2]成都中医药大学附属医院,四川 成都

出　　处：《中医学》2024年第11期3160-3167,共8页Traditional Chinese Medicine

摘　　要：视网膜色素变性(RP)是最常见的遗传性视网膜疾病之一,具有较高的全球发病率。其潜在的病理机制涉及视神经的退行性改变和视网膜的逐渐损伤,首先表现为杆状感光细胞的损失,随后影响锥状感光细胞。RP的发病机制复杂,目前尚无单一的有效治疗方法。中医学以整体观念和辨证论治为基础,在维持视功能、延缓疾病进展等方面展现出一定的优势。本文对近年来中医药治疗RP的相关研究进行了回顾,重点从RP的发病机制、中药治疗、针刺疗法以及针药结合等方面进行综述,并对中医药治疗RP的不足与未来发展方向提出了展望。Retinitis pigmentosa (RP) is one of the most common inherited retinal diseases, with a high global incidence rate. The underlying pathological mechanisms involve degenerative changes in the optic nerve and progressive damage to the retina, initially manifesting as loss of rod photoreceptors, followed by cone photoreceptors. The pathogenesis of RP is complex, and no single effective treatment currently exists. Traditional Chinese medicine (TCM), based on the holistic concept and syndrome differentiation, demonstrates certain advantages in maintaining visual function and slowing disease progression. This paper reviews recent studies on the treatment of RP with TCM, focusing on the pathogenesis of RP, herbal medicine treatment, acupuncture therapy, and the combination of acupuncture and herbal medicine. It also provides an outlook on the shortcomings of TCM treatment for RP and future development directions.

关 键 词：视网膜色素变性 中医药 病理机制 研究进展 

分 类 号：R24[医药卫生—中医临床基础]